Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications
International Journal of Molecular Sciences · 05.12.2024 · 25 (23) · 13096
DOI: 10.3390/ijms252313096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.12.2024. Verfasst von Chiara Siracusa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Vascular Calcification, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vascular calcification (VC) is a biological phenomenon characterized by an accumulation of calcium and phosphate deposits within the walls of blood vessels causing the loss of elasticity of the arterial walls. VC plays a crucial role in the incidence and progression of chronic kidney disease (CKD), leading to a significant increase in cardiovascular mortality in these patients. Different conditions such as age, sex, dyslipidemia, diabetes, and hypertension are the main risk factors in patients affected by chronic kidney disease. However, VC may occur earlier and faster in these patients if it is associated with new or non-traditional risk factors such as oxidative stress, anemia, and inflammation. In chronic kidney disease, several pathophysiological processes contribute to vascular calcifications, including osteochondrogenic differentiation of vascular cells, hyperphosphatemia and hypercalcemia, and the loss of specific vascular calcification inhibitors including pyrophosphate, fetuin-A, osteoprotegerin, and matrix GLA protein. In this review we discuss the main traditional and non-traditional risk factors that can promote VC in patients with kidney disease. In addition, we provide an overview of the main pathogenetic mechanisms responsible for VC that may be crucial to identify new prevention strategies and possible new therapeutic approaches to reduce cardiovascular risk in patients with kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
- Department of Experimental and Clinical Medicine, "Magna Grecia" University, 88100 Catanzaro, Italy.
- Department of Health Sciences, "Magna Grecia" University, 88100 Catanzaro, Italy.
ORCID-Profile: Antonio Strangio, Eleonora Cianflone, Daniele Torella, Michele Andreucci, Davide Bolignano, Giuseppe Coppolino, Salvatore De Rosa
Zitieren
APA
Siracusa, C., Carabetta, N., Morano, M. B., Manica, M., Strangio, A., Sabatino, J., Leo, I., Castagna, A., Cianflone, E., Torella, D., Andreucci, M., Zicarelli, M. T., Musolino, M., Bolignano, D., Coppolino, G., & De Rosa, S. (2024). Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications. International Journal of Molecular Sciences, 25(23), 13096. https://doi.org/10.3390/ijms252313096
Vancouver
Siracusa C, Carabetta N, Morano MB, Manica M, Strangio A, Sabatino J, et al. Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications. International Journal of Molecular Sciences. 2024;25(23):13096. doi:10.3390/ijms252313096
BibTeX
@article{Siracusa2024,
author = {Siracusa, Chiara and Carabetta, Nicole and Morano, Maria Benedetta and Manica, Marzia and Strangio, Antonio and Sabatino, Jolanda and Leo, Isabella and Castagna, Alberto and Cianflone, Eleonora and Torella, Daniele and Andreucci, Michele and Zicarelli, Maria Teresa and Musolino, Michela and Bolignano, Davide and Coppolino, Giuseppe and De Rosa, Salvatore},
title = {Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13096},
doi = {10.3390/ijms252313096}
}
EUVIMED